Clicking on any of the links below will take you to a Web site to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every Web site you visit.

J&J News

Click here to access the latest news from our parent company, Johnson & Johnson.

Portfolio Company News

Find the latest investment news from our portfolio companies.

January 5, 2012
Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences

October 20, 2011
Syntaxin and Ipsen Enter into a Strategic Agreement to Develop Novel Botulinum-toxin Therapeutics

October 18, 2011
iScience Interventional Announces Clinical and Commercial Supply Agreement

August 30, 2011
GI's successful raising lifts IPO market dynamics

August 8, 2011
Johnson & Johnson invests in Israel's LifeBond

July 20, 2011
SuperGen Completes Acquisition of Astex Therapeutics

July 19, 2011
Nevro Corp Closes $58 Million in New Financing

July 18, 2011
Atlas Genetics Ltd Completes £16.9 million Series B Financing led by Novartis Venture Funds

June 27, 2011
Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation

June 16, 2011
Five Prime Therapeutics Provides an Update on its Strategic Discovery Collaborations with Pfizer and GlaxoSmithKline

June 15, 2011
Spinal Modulation Secures $30 Million Series D Financing

May 23, 2011
Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo

May 11, 2011
Light Sciences Oncology Elects Dennis Langer, M.D., J.D. to Its Board of Directors

May 4, 2011
Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases

January 6, 2011
Zeo, Inc. Announces $12.3 Million Venture Financing

January 3, 2011
Genocea Biosciences Closes $35 Million Series B Financing

November 30, 2010
PhaseBio Launches Clinical Program to Test Lead Product for Sustained 24/7 Glycemic Control in Type 2 Diabetics

November 11, 2010
Syntaxin raises £18 million in new financing

November 9, 2010
23andMe Raises More Than $22 million in Series C Financing

August 3, 2010
Five Prime Therapeutics, Inc. Announces Strategic Alliance with GlaxoSmithKline to Discover Innovative Biologics for Skeletal Muscle Disorders

July 15, 2010
Biolex and Merial Broaden Collaboration

July 8, 2010
NeuroPace Submits PMA Application for FDA Approval of Novel Investigational Device for Epilepsy

June 22, 2010
Metabolex Enters Into Type 2 Diabetes Development and License Agreement

June 17, 2010
Aquinox Pharmaceuticals completes US $25 million Series B financing

May 18, 2010
Breathe Technologies Secures $23 Million in Series C Financing

April 30, 2010
Molecular Partners progresses DARPin into first-in-humans clinical studies

April 28, 2010
Celladon Corp. Announces that MYDICAR® Meets Primary Endpoint in Phase 2 Trial for Treatment of Advanced Heart Failure

April 15, 2010
Biolex Announces Presentation at EASL OF Interim Results From Select-2 Phase2b Trial of Locteron® in Chronic Hepatitis C

April 13, 2010
Encouraging data from three Astex collaborative programmes to be presented at the 101st American Association for Cancer Research (AACR) Annual Meeting 2010

April 7, 2010
iScience Interventional, Inc Enters into a Collaborative Supply Agreement with Centocor Research and Development, Inc on a Minimally-Invasive Approach to Deliver Cell Therapies

March 3, 2010
Study Demonstrates People Living with Type 2 Diabetes and Obesity Can Be Successfully Treated with GI Dynamics' EndoBarrier™ Gastrointestinal Liner for 12 Months

February 25, 2010
Light Sciences Oncology Meets a Major Milestone in Aptocine Development With Target Enrollment in Phase 3 MCRC Trial

February 24, 2010
Five Prime Therapeutics, Inc. Announces Milestone for Therapeutic Program

February 12, 2010
CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial

January 20, 2010
Ethicon Completes Acquisition of Acclarent

January 7, 2010
GI Dynamics Receives Strategic Investment from Medtronic, Inc.

January 7, 2010
PhaseBio Pharmaceuticals, Inc. Raises $25 Million in Series B Funding, Initiates Collaboration with OSI Pharmaceuticals

January 6, 2010
Insound® Medical Acquired by Sonova

December 15, 2009
Molecular Partners Secures CHF 46 million in Series B Financing Led by Essex Woodlands Health Ventures

November 4, 2009
Spinal Modulation Completes $27.4 Million Financing

August 17, 2009
NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV

June 22, 2009
CoAxia, Inc. Announces $21.5M Series D Financing

April 23, 2009
iScience Interventional receives $20.5 million in Series F funding

February 19, 2009
GI Dynamics Closes an Additional $15 Million in Series C Financing

January 7, 2009
GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System

December 3, 2008
Catalyst Biosciences Raises $40 Million in Series C Financing

November 19, 2008
Tengion Announces Second Closing of Series C Financing

October 6, 2008
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C

July 30, 2008
CVRx Closes $84 Million Financing (PDF)